H
Hospital Pablo Tobon Uribe | Clinical Research Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ACE-536
Luspatercept
Carfilzomib
Mezigdomide
MeziKD
Dexamethasone
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexameth...
Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Mezigdomide
Drug: Dexamethasone
The purpose of this Phase 3 study is to evaluate the efficacy and safety of Luspatercept compared with placebo in subjects with myeloproliferative ne...
Active, not recruiting
Anemia
Myelofibrosis
Other: Placebo
Drug: ACE-536
The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to IPSS-R ver...
Enrolling
Myelodysplastic Syndromes
Biological: Epoetin Alfa
Biological: Luspatercept
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems